On the other hand, inflammasome activation enhances the tumorilytic activity of CD8+ T cells and NK cells in an IL-18-dependent manner, and further promotes anti-tumor immunity through pyroptosis, an immunogenic cell death that activates antigen-presenting cells through the release of tumor antigens and adjuvants in the TME. This evidence concerns the gene IL18 and neoplasm.